Difference between revisions of "ICRP Glossary"
| Line 44: | Line 44: | ||
*[[Acute Exposure]] | *[[Acute Exposure]] | ||
| + | |||
| + | *Acute radiation sickness (see *[[Acute radiation syndrome]]) | ||
*[[Acute radiation syndrome]] | *[[Acute radiation syndrome]] | ||
| Line 82: | Line 84: | ||
*[[Area monitoring]] | *[[Area monitoring]] | ||
| + | |||
| + | *ARS (see [[Acute radiation syndrome]]) | ||
*[[Attributable risk]] | *[[Attributable risk]] | ||
| Line 198: | Line 202: | ||
=== <big><span id="D">D</span></big> === | === <big><span id="D">D</span></big> === | ||
| + | |||
| + | *DD (see [[Doubling dose)]]) | ||
| + | |||
| + | *DDREF (see [[Dose and dose-rate effectiveness factor)]]) | ||
*[[Decay constant]] | *[[Decay constant]] | ||
| Line 233: | Line 241: | ||
*[[DNA damage signalling]] | *[[DNA damage signalling]] | ||
| − | *[[Dose and dose-rate effectiveness factor | + | *[[Dose and dose-rate effectiveness factor)]] |
*[[Dose constraint]] | *[[Dose constraint]] | ||
| Line 282: | Line 290: | ||
*[[Elemental dose]] | *[[Elemental dose]] | ||
| + | |||
| + | *ELR (see *[[Excess lifetime risk]] | ||
*[[Emergency]] | *[[Emergency]] | ||
| Line 410: | Line 420: | ||
*[[Incidence]] | *[[Incidence]] | ||
| + | |||
| + | *Incidence rate (see [[Incidence]]) | ||
*[[Incident]] | *[[Incident]] | ||
| Line 484: | Line 496: | ||
*[[Linear-quadratic dose response]] | *[[Linear-quadratic dose response]] | ||
| + | |||
| + | *LLE (see [[Loss of Life Expectancy]]) | ||
*[[Loss of Life Expectancy]] | *[[Loss of Life Expectancy]] | ||
| Line 494: | Line 508: | ||
*[[Low level waste]] | *[[Low level waste]] | ||
| + | |||
| + | *LSS (see [[Life span study]]) | ||
*[[Lymphatic system]] | *[[Lymphatic system]] | ||
| Line 532: | Line 548: | ||
*[[Neurovascular syndrome]] | *[[Neurovascular syndrome]] | ||
| + | |||
| + | *NHEJ (see [[Non-homologous end joining]]) | ||
*[[Nominal risk coefficient]] | *[[Nominal risk coefficient]] | ||
| Line 578: | Line 596: | ||
*[[Platelet-derived growth factor]] | *[[Platelet-derived growth factor]] | ||
| + | |||
| + | *PLDR (see [[Potentially lethal damage repair]]) | ||
*[[Pooled analysis]] | *[[Pooled analysis]] | ||
| Line 660: | Line 680: | ||
*[[Radiosensitivity, cellular]] | *[[Radiosensitivity, cellular]] | ||
| + | |||
| + | *RBE (see [[Relative biological effectiveness]]) | ||
| + | |||
| + | *RAP (see [[Reference Animal and Plant]]) | ||
*[[Reactive oxygen species]] | *[[Reactive oxygen species]] | ||
| Line 678: | Line 702: | ||
*[[Reference level]] | *[[Reference level]] | ||
| + | |||
| + | *REID (see [[Risk of exposure-induced death]]) | ||
*[[Rehabilitation of living conditions]] | *[[Rehabilitation of living conditions]] | ||
| Line 724: | Line 750: | ||
*[[Risk of exposure-induced death]] | *[[Risk of exposure-induced death]] | ||
| + | |||
| + | *ROS (see [[Reactive oxygen species]]) | ||
*[[Routine monitoring]] | *[[Routine monitoring]] | ||
| + | |||
| + | *RR (see [[Relative risk]]) | ||
=== <big><span id="S">S</span></big> === | === <big><span id="S">S</span></big> === | ||
| Line 740: | Line 770: | ||
*[[Severe deterministic injury]] | *[[Severe deterministic injury]] | ||
| + | |||
| + | *SLDR (see [[Sublethal damage repair]]) | ||
*[[Slow repair]] | *[[Slow repair]] | ||
Revision as of 21:15, 24 February 2021
The ICRP Glossary collects ICRP’s definitive explanations of terms for current use. It is a living document, updated regularly. Each entry shows the date it was last updated, and some include past glossary entries to help readers better understand the term in a particular context.
Many ICRP publications have included their own glossaries. The ICRP Glossary includes most of the terms in these other glossaries, many with updated entries. ICRP publications will continue to have their own glossaries when necessary, for example for highly specialized terms relevant to a single publication or helpful for a reader to have close at hand, or when introducing a new term which would also be added to the ICRP Glossary.
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
The ICRP Glossary shown here comprises some 400 terms. Entries for an additional approximately 400 terms are being added progressively.
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ... |
A
- Acute radiation sickness (see *Acute radiation syndrome)
- ARS (see Acute radiation syndrome)
B
C
D
- DD (see Doubling dose))
- DDREF (see Dose and dose-rate effectiveness factor))
E
- ELR (see *Excess lifetime risk
F
G
H
I
- Incidence rate (see Incidence)
J
K
L
- LLE (see Loss of Life Expectancy)
- LSS (see Life span study)
M
N
- NHEJ (see Non-homologous end joining)
O
P
- PLDR (see Potentially lethal damage repair)
Q
R
- RBE (see Relative biological effectiveness)
- RAP (see Reference Animal and Plant)
- REID (see Risk of exposure-induced death)
- ROS (see Reactive oxygen species)
- RR (see Relative risk)
S
- SLDR (see Sublethal damage repair)
